Quiz 14 Flashcards

1
Q

K sparing Diuretics

Mineralcorticoid Receptor Antagonists

A
  • Aldosterone, a steroid hormone, is secreted by the adrenal cortex, and is a potent mineral corticoid.
  • Acting on the distal tubule and collecting ducts of the nephron, it causes increased reabsorption of Na+ and Cl– ions and water, while increasing K+-ion ion excretion
  • Aldosterone action leads to increase in water retention, and increased blood pressure / volume.
  • The biologic effect of Aldosterone is caused by its binding to the mineralcorticoid receptor (MR), a nuclear transcription factor
  • Inhibition (antagonism) of aldosterone function can lead to diuresis (excretion of Na+, and Cl– ions and water)
  • Such inhibitors are also classified as Potassium-Sparing Diuretics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Renin?

Type of enzyme?

A

Protease

Angiotensinogen to form Angiotensin I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RAS drug target?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Osmotic Diuretics?

A
  • Low molecular weight compounds
  • Passively filtered through Bowman’s capsule into renal tubule.
  • Limited reabsorption.
  • Undergoes negligible metabolism
  • Forms hypertonic solution, causing water to secrete into renal tubule, producing a diuretic effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The action of ACE results in?

A
  • Generation of a potent hypertensive agent Angiotensin II
  • Release of a hypertensive agent Aldosterone
  • Degradation of a potent antihypertensive agent Bradykinin (a vasodilator)
  • The outcome of all the above actions of ACE is hypertension, an increase in blood pressure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Losartan

A
  • The first clinically approved ARB drug (1995)
  • Highly protein bound (~98%); Adequate oral bioavailability (33%)
  • Approximately 14% of an oral dose is oxidized by the isozymes CYP2C9 and CYP3A4 to a more potent (10-40 times) carboxylic acid metabolite
    • (-CH2OH —-> -CO2H)
  • Primarily excreted by the fecal route.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diuretic Sites of Action

A

Proximal Tubule; Loop of Henle; Collecting Tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Carbonic Anhydrase Inhibitors?

A
  • Presence of an acidic sulfonamide group (pKa= 7–9). Free N–H required for activity.
  • Site of Action: Proximal Convoluted Tubule
  • Not very efficacious (increases renal excretion of sodium only by 2%–5%)
  • Limited use, mostly for the treatment of glaucoma (oral and topical formulations)
  • First orally effective CA inhibitor diuretic in clinical use § Diuretic effect lasts for 8 – 12 hrs § Limited use because of systemic acidosis
  • AEs-
    • Development of metabolic acidosis on prolonged use
    • Can cause electrolyte disturbance (hypokalemia) and renal effects (kidney stone)
    • Hypersensitivity reactions possible (attributable to sulfonamide group)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Carbonic Anyhydrase?

A
  • Carbonic anhydrase (CA), a metalloenzyme (Zn2+-ion at active site), catalyzes the formation of carbonic acid (H2CO3) from carbon dioxide and water.
  • At least seven CA isozymes in human, present mainly in blood cells, gastric mucosa, pancreatic cells, and renal tubules.
  • In the proximal tubule, promotes reabsorption of Na+ and HCO3 – ions from the glomerular filtrate, and excretion of H+ ions. (Acidic nature of urine and alkalinity of blood)
  • Inhibition of carbonic anhydrase induces diuresis via excretion of sodium and bicarbonate ions, and associated water molecules.
  • Accidental initial discovery of carbonic anhydrase inhibitory activity (in dog urine!) of Sulfanilamide, a sulfonamide antibacterial.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACE

Contains?

Cleaves peptides with? But not?

Hydrolyzes Ang I and also?

A
  • Zn2+
  • Tripeptide sequence but not cleave peptides with penultimate prolyl residue
  • Bradykinin and Substance P
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ang II receptor blockers application

AEs

DIs

A
  • All the ARBs are approved for the treatment of hypertension. Can be used as stand-alone drugs, or in combination with other anti-hypertensive agents (e.g. Diuretics; Calcium channel blockers).
  • Additionally, some of the ARBs also find use in the treatment of nephropathy in type 2 diabetes (Losartan / Irbesartan), heart failure (Candesartan / Valsartan), and cardiovascular risk-reduction of MI and stroke (Telmisartan) etc.

AEs

  • ARBs are generally well tolerated. Unlike ACE inhibitors, does not effect the levels of bradykinin or prostaglandins. The most common side-effects include:
  • Headache; Dizziness; Fatigue; Hypotension; Upper respiratory tract infection etc. q ARBs are contraindicated during pregnancy.

DIs

  • ARBs are relatively free of clinically important drug interactions. Telmisartan is the only agent among this class reported to increase the plasma concentration of Digoxin.
  • However, non-steroidal antiinflammatory drugs (NSAIDs) may alter the response to ARBs and other anhtihypertensive agents (including ACE inhibitors and Ca2+-channel blockers) due to the inhibition (COX) of vasodilatory prostaglandins.
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Other examples of ACEs in Dicarboxylate group

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Angiotensin II is a?

What is its precursor?

Angiotensin II is also responsible for?

A
  • Potent vasodilator
  • Angiotensinogen
  • Production of Aldosterone which in turn contributes towards an increase in plasma volume and Bp.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Properties of loop di table

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Captopril Metabolic Pathway

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AEs of ACE-Is

A
  • Generally well-tolerated drugs. Serious untoward reactions are rare.
  • Side effects may include, hypotension, hyperkalemia, dry cough (in 5-20% of patients), dizziness, renal insufficiency, skin rash, neutropenia (rare), and angioedema etc.
  • The use of ACE inhibitors during pregnancy (especially during 2nd / 3rd trimester) is contraindicated
  • Renal elimination is the primary route of elimination for majority of the ACE inhibitors (except Fosinopril). Therefore, dosage should be reduced in patients with renal impairment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The difference in ACE classes? 3 ways

A
  • In their potency
  • Whether the activity is due to the drug itself, or the conversion of a prodrug to an active metabolite
  • Pharmacokinetics (extent of absorption; effect of food; plasma half-life; tissue distribution; mechanism of elimination etc)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SAR of Thiazide Diuretics?

A
  • C7-position: Sulfonamide group is required for activity
  • C6-position (R1): Electron-withdrawing group (e.g. Cl, CF3 etc) required for activity
  • 3–4-position: Saturation of the double bond results in more potent (~ 10-fold) analogs
  • C3-position (R2): Lipophilic group improves diuretic potency
  • 2-position (R3): N-alkyl substitution increases the duration of diuretic action
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Angiotensin I is converted to? By?

A

to Ang II by ACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Loop Diuretics?

A
  • Diverse structural classes
  • The most efficacious among the various diuretic classes
  • Peak diuresis produced > other commonly used diuretics (High-Ceiling Diuretics)
  • Site of Action: Loop of Henle (thick ascending limb)
  • Inhibits the luminal Na+/ K+/ 2Cl- co-transporter
  • Characterized by quick onset (~ 30 min) and relatively short duration of action (~ 6 hrs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Enalapril

A
  • An ester prodrug. Hydrolyzed by hepatic esterase to the active carboxylic acid form. Dicarboxylate class of ACE inhibitor.
  • More potent than Captopril.
  • Oral drug; Readily absorbed; Oral bioavailability ~ 60%, not reduced by food. Eliminated unchanged in urine
  • Enalaprilat not absorbed orally. Available in IV formulation.
  • Used for the therapy of hypertension and heart failure; Only ACE inhibitor approved for pediatric use.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Fosinopril

A
  • Phosphinate group containing ACE inhibitor.
  • A prodrug. Cleavage of the ester moiety by hepatic esterases generates the active drug Fosinoprilat
  • Slowly and incompletely (36%) absorbed after oral administration.
  • Fosinoprilat and glucuronide conjugate excreted in urine and bile; Clearance not significantly altered by renal impairment.
  • Indicated for the treatment of hypertension and heart failure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Candesartan cilexitil

A
  • Inactive ester prodrug. Completely hydrolyzed during absorption from the GI tract to form the active drug Candestran; High plasma protein binding (99%); Oral bioavailability = 15%; T1/2 = 9 hrs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What two major enzymes are involved in the RAS?

A

Renin and Angiotensin Converting Enzyme

25
Q

Captopril

A
  • First ACE inhibitor drug (1981); Contains a sulfhydryl (SH) group
  • Oral drug; Rapid absorption; Bioavailability ~ 75%; T1/2 = 2 hrs
  • Partially eliminated unchanged in urine (~50%), remainder as disulfide dimer and captopril-cysteine disulfide
  • Used for the therapy of hypertension and heart failure
  • Food reduces oral bioavailability by 25-30%
  • Sulfhydryl group implicated in skin rashes and taste disturbance
26
Q

Average GFR?

Urine formation represents how much of total filtration?

What percentage of water is reabsorbed?

A
  • 120
  • 1-2%
  • 98%
27
Q

Spironolactone

A
  • A semi-synthetic drug. Prevents aldosterone binding (antagonist) to the MR in the distal convoluted tubule and the collecting system.
  • Causes increased amount of Na+ / water excretion, and retention of K+-ion.
  • Oral drug (90% availability). Undergoes significant first-pass metabolism to form Canrenone (loses Me–CO–SH), an active metabolite. Excretetion mainly in urine.
  • Adverse effects: Can cause hyperkalemia. Use of other K+-sparing diuretics, potassium supplements and food rich in potassium should be avoided. Anti-androgenic effects, hypersensitivity reactions, GI disturbances, and peptic ulcer have also been reported.
28
Q

Torsemide

A
  • Sulfonylurea side-chain instead of sulfonamide
  • Same site / mechanism of action as furosemide and bumetanide
  • Available in oral and parenteral (IV) forms
  • Partially metabolized by hepatic cytochrome P450 enzymes. A major metabolic route involves oxidn of the Ar-Me group to carboxylic acid.
  • Uses: Treatment of hypertension; Congestive heart failure and cirrhosis associated edema.
  • Adverse Effects : Fatigue, dizziness, muscle cramps, nausea and orthostatic hypotension.
29
Q

Diuretic drug classes are classified by?

A
  • Chemical Class (eg. thiazides);
  • Mechanism of Action (eg. Carbonic Anhydrase Inhibitors);
  • Site of Action within the nephron (eg. Loop Diuretics);
  • Effects on Urine contents (Potassium- Sparing Diuretics) etc.
30
Q

Diuretics

  1. Agents which _____ the rate of urine formation.
  2. Diuretic usage leads to _____ excretion of _____ (especially Na+ and Cl- ions) and water.
  3. Useful in the treatment of _____ conditions caused by?
  4. Diuretics are also used as the ____ agent or as ____therapy in the treatment of?
  5. The primary site of action for the diuretics is?
A
  1. Agents which increase the rate of urine formation.
  2. Diuretic usage leads to increased excretion of electrolytes (especially Na+ and Cl- ions) and water.
  3. Useful in the treatment of edematous conditions caused by congestive heart failure, nephritic syndrome, chronic liver disease etc., and in the management of hypertension.
  4. Diuretics are also used as the sole agent or as adjunctive therapy in the treatment of glaucoma, hypercalcemia, mountain sickness etc.
  5. The primary site of action for the diuretics is the kidney, where these drugs interfere with the reabsorption of sodium and other ions.
31
Q

Thiazide-like Diuretics

Quinazolinone

A
  • Contains a quinazolin-4-one structural core (ring-SO2 of thiazides replaced with a CO group)
  • Diuretic effects similar to the thiazide class of compounds
  • Orally active. Long duration of action (upto 24 hrs)
  • Adverse effects similar to the thiazide diuretic class
32
Q

Angiotensinogen

Hydrolyzed by? to release?

A

Renin to release angiotensin I

33
Q

RAS a Bp Elevation picture

A
34
Q

Other ARBs in use

Features of all ARBs

A
  • All the ARBs are acidic drugs. The tetrazole ring has a pKa ≃ 6, and the carboxylic acid pKa = 3-4.
  • Azilsartan medomoxil and Olmesartan medomoxil are prodrugs that are completely hydrolyzed during absorption from the GI tract to generate the active carboxylic acid metabolites.
35
Q

Comparison Table of K sparing Diuretics

A
36
Q

Amiloride

A
  • An aminopyrazine derivative.
  • Renal epithelial Na+ channel blocker. Blocks the reabsorption of Na+- ion and secretion of K+-ion in DCT. No effect on aldosterone action.
  • Oral drug (~50% absorption). Excreted (mostly unchanged) in urine and feces. Renal impairment can increase half-life.
  • Adverse Effects: Similar to triamterene.
37
Q

Benzapril

A
  • A prodrug; Ester hydrolysis produces the active drug.
  • Belongs to the dicarboxylate class of ACE inhibitors
  • More potent than captopril or enalaprilat
  • Oral drug. Indicated for hypertension.
  • Readily but incompletely absorbed. Glucuronide conjugate excreted via urine and bile.
  • Also available in combination with Hydrochlorothoazide (Lotensin HCT®) or Amlodipine (Lotrel®)
38
Q

What is the RAS?

A

Highly regulated pathway, integral in regulating arterial blood pressure, body fluid volume, and electrolyte balance

39
Q

Ang II receptor blockers MOA?

AT1 receptor

AT2 receptor

A
  • Also called receptor antagonists, displace/prevents binding of angiotensin II at the binding site
  • Located in brain, neuro, vascular, renal, hepatic, adrenal, myocardial mediate effects at these sites
  • 2 is growth, development
40
Q

Osmotic Diuretic Examples

Which one has greater absorption? Longer half life? Duration of action?

A
  • Isosorbide greater absorption longer t half
  • Mannitol greater DOA
  • Not a frequently used class of diuretics in current practice, except in the prophylaxis of acute renal failure to inhibit water reabsorption and maintain urine flow.
  • Mannitol is the agent most commonly used as an osmotic diuretic.
  • Administered as an intravenous solution.
  • Isosorbide (a bicyclic form of sorbitol!) is primarily used for the treatment of glaucoma.
41
Q

Pharmacokinetics of ARBs

A
42
Q

Ethacrynic

A
  • A phenoxyacetic acid derivative. Lacks a sulfonamide group.
  • Same site / mechanism of action as the above loop diuretics
  • Rapid onset (~ 30 min) and long duration of action (6 – 8 hr)
  • Oral and parenteral. Highly plasma protein bound (> 95%)
  • Relatively less potent than the other drugs in this category. However, useful in patients who are allergic to the sulfonamides.
  • Adverse effects: Greater incidences of ototoxicity and more serious gastrointestinal effects
43
Q

Site of Mechanism of Action of Diuretics Summary

A
44
Q

DIs of ACE-Is

A
  • Antacids may reduce bioavailability. NSAIDS (including aspirin) may reduce the anti-hypertensive response to ACE inhibitors.
45
Q

Thiazide examples

A
  • Used in the treatment of edema caused by congestive heart failure as well as in hepatic or renal disease. Also useful in the treatment of hypertension (reduction in blood volume)
  • Compared to Chlorothiazide, the double bond reduced analog Hydrochlorothiazide (HCT) is more potent and has a longer half-life.
  • Adverse Effects: Gastric irritation, hypersensitivity, nausea, and electrolyte disturbance. Long-term use may also result in decreased glucose tolerance and increased blood lipid content (TC, LDL, TG).
46
Q

Overview of Site of Mechanism of Action Picture

A
47
Q

SAR of ACE Is

A
  • The N-ring carboxylic acid is essential (mimics the C-terminal carboxylate of ACE substrates)
  • Large hydrophobic functionalities in the N-ring increases potency
  • Zn-ion binding groups (sulfhydryl, carboxylate, phosphinic acid etc) required for potency
  • ‘X’ is usually methyl (mimics the side-chain of alanine), the exception being Lisinopril
  • For optimum activity, stereochemistry should be consistent with natural L-amino acid
48
Q

Triametrene

A
  • Contains a pteridine sturctural core.
  • Renal epithelial Na+ channel blocker. Blocks the reabsorption of Na+ ion and prevents excretion of K+ ion in the distal tubule (but no effect on aldosterone action).
  • Oral drug (~70% absorption). Metabolized extensively (4’-OH analog and its sulfate conjugate). Excreted in the urine
  • Adverse Effects: Can cause hyperkalemia, nausea, vomiting and headache. Potassium supplements are contraindicated, and serum potassium levels should be monitored.
49
Q

Captopril Binding site interaction?

A
50
Q

ACEs can be classified into three groups based on their structure

A
  • Sulfhydryl (SH) group containing inhibitors (e.g. Captopril)
  • Dicarboxylate-containing inhibitors (e.g. Enalapril)
  • Phosphonate-containing inhibitors (e.g. Fosinopril)
51
Q

Comparison of Triametrene and Amiloride

A
52
Q

Furosemide

A
  • Contains a carboxylic acid functional group (pKa ~4)
  • 8 – 10 Times stronger saluretic action than the thiazides.
  • Causes excretion of Na+, K+, Ca2+, Mg2+, Cl- and HCO3 - ions
  • Orally active. Parenteral form for faster onset of action.
  • Extensive plasma protein binding (> 90%). Mostly excreted unchanged (kidney).
  • Uses-Most important use in the treatment of pulmonary edema. Additional uses include, treatment of edemas associated with cardiac, hepatic and renal malfunctions. Also useful in the treatment of hypertension.
  • Side-Effects: Electrolyte Imbalance; Hyperuricemia; Gastrointestinal side-effects, and hypersensitivity etc. Can also cause ototoxicity (temporary hearing loss). This effect can be additive with concurrent usage of aminoglycoside antibiotics.
53
Q

Eplerenone

A
  • An aldosterone antagonist. Compared to Spironolactone, lower affinity for MR, however a more selective inhibitor (does not inhibit AR, PR, and GR)
  • Oral drug (~70% availability). T1/2≃ 5 hr. Hepatic metabolism (CYP3A4). Metabolites inactive and excreted in urine and feces.
  • Adverse effects: Can cause hyperkalemia. However, unlike spironolactone, limited/fewer sexual side effects.
54
Q

Ang III does not have any vasoconstriction properties but it does?

A

Stimulate Aldosterone secretion which increases plasma volume and blood pressure

55
Q

Pharmacokinetic Properties of ACEs table

A
56
Q

HTN is a risk factor for?

A

Stroke, MI, Renal Failure, CHF, Progressive Atherosclerosis and Dementia

57
Q

Renin

Only drug in class

A
  • Development of Aliskiren: The First (and only) Renin Inhibitor in Clinical Use
58
Q

Thiazide Diuretics?

A
  • Further modified sulfonamides, characterized by the presence of a benzothiadiazine 1,1-dioxide core
  • Weakly acidic compounds (pKa ~ 7). Actively secreted into the proximal tubule and are carried to the site of action.
  • Site of Action: Thick ascending loop of Henle and distal convoluted tubule
  • Mechanism of Diuretic Action: Binds to the Na+/Cl– symporter and inhibits the reabsorption of sodium and chloride ions (saluretic agents)
  • Used alone, or as add-on therapy. Rapid oral absorption. Excreted mainly unchanged (urine)
59
Q

Bumetanide

A
  • Ring substitution pattern different than furosemide
  • Greater bioavailability than furosemide
  • Marked increase in diuretic potency (~ 40 times of furosemide)
  • Uses and side effect profile similar to furosemide